ES2106088T3 - Liposomas que proporcionan una ayuda timo-dependiente a antigenos de vacuna debiles. - Google Patents

Liposomas que proporcionan una ayuda timo-dependiente a antigenos de vacuna debiles.

Info

Publication number
ES2106088T3
ES2106088T3 ES91918697T ES91918697T ES2106088T3 ES 2106088 T3 ES2106088 T3 ES 2106088T3 ES 91918697 T ES91918697 T ES 91918697T ES 91918697 T ES91918697 T ES 91918697T ES 2106088 T3 ES2106088 T3 ES 2106088T3
Authority
ES
Spain
Prior art keywords
liposomes
timo
aid
dependent
vaccine antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91918697T
Other languages
English (en)
Inventor
Howard R Six
Nathalie Garcon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Development Foundation
Original Assignee
Research Development Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Development Foundation filed Critical Research Development Foundation
Application granted granted Critical
Publication of ES2106088T3 publication Critical patent/ES2106088T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA RESPUESTA DE ANTICUERPOS A UN ANTIGENO BLANCO PUEDE SER AUMENTADA POR INCORPORACION DEL ANTIGENO A UN LIPOSOMA CON UN CONSTITUYENTE ADICIONAL QUE CONTIENE AL MENOS UN LUGAR DE RECONOCIMIENTO DE LINFOCITOS T_HELPER. LOS LIPOSOMAS PUEDEN INCLUIR UNA AMPLIA VARIEDAD DE MATERIALES LIPIDICOS. AMBOS EL ANTIGENO Y EL LUGAR DE RECONOCIMIENTO DE LINFOCITOS T_HELPER QUE CONTIENEN CONSTITUYENTES PUEDEN SER ASOCIADOS CON LOS LIPOSOMAS POR MEDIO DEL USO DE INTERACCIONES HIDROFOBICAS O POR UNION COVALENTE A UN LIPIDO.
ES91918697T 1990-07-27 1991-07-24 Liposomas que proporcionan una ayuda timo-dependiente a antigenos de vacuna debiles. Expired - Lifetime ES2106088T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55896090A 1990-07-27 1990-07-27

Publications (1)

Publication Number Publication Date
ES2106088T3 true ES2106088T3 (es) 1997-11-01

Family

ID=24231699

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91918697T Expired - Lifetime ES2106088T3 (es) 1990-07-27 1991-07-24 Liposomas que proporcionan una ayuda timo-dependiente a antigenos de vacuna debiles.

Country Status (22)

Country Link
US (1) US5464630A (es)
EP (1) EP0542923B1 (es)
JP (1) JP3518866B2 (es)
KR (1) KR100213851B1 (es)
CN (1) CN1032236C (es)
AT (1) ATE157537T1 (es)
AU (1) AU650299B2 (es)
CA (1) CA2088163C (es)
DE (1) DE69127545T2 (es)
DK (1) DK0542923T3 (es)
ES (1) ES2106088T3 (es)
FI (1) FI107515B (es)
GR (1) GR3025377T3 (es)
HK (1) HK1008304A1 (es)
IE (1) IE912535A1 (es)
IL (1) IL98935A (es)
NO (1) NO311167B1 (es)
NZ (1) NZ239072A (es)
PT (1) PT98470B (es)
RU (1) RU2107493C1 (es)
WO (1) WO1992002243A1 (es)
ZA (1) ZA915755B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879685A (en) * 1991-05-08 1999-03-09 Schweiz, Serum- & Impfinstitut Bern Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
US6004534A (en) * 1993-07-23 1999-12-21 Massachusetts Institute Of Technology Targeted polymerized liposomes for improved drug delivery
WO1996007102A1 (en) * 1994-09-01 1996-03-07 Wisconsin Alumni Research Foundation Therapeutic remodeling in aids
US6060082A (en) * 1997-04-18 2000-05-09 Massachusetts Institute Of Technology Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
AUPO732997A0 (en) * 1997-06-12 1997-07-03 Csl Limited Ganglioside immunostimulating complexes and uses thereof
US5993852A (en) * 1997-08-29 1999-11-30 Pharmaderm Laboratories Ltd. Biphasic lipid vesicle composition for transdermal administration of an immunogen
US6027731A (en) * 1998-11-17 2000-02-22 Wisconsin Alumni Research Foundation Pertussis toxin induced lymphocytosis
JP4685350B2 (ja) * 2001-07-26 2011-05-18 オタゴ イノベイション リミティド 抗原性組成物
JP2009510032A (ja) * 2005-09-30 2009-03-12 リポクセン テクノロジーズ リミテッド 多糖抗原及びタンパク質アジュバントを含む多価リポソームワクチン組成物
RU2480479C1 (ru) * 2011-11-01 2013-04-27 Елена Викторовна Свирщевская Гетерологичный пептидный мини-антиген в составе полимерной частицы для создания противоаллергенной вакцины
DK2800762T3 (en) 2012-01-03 2018-04-16 Us Health NATIVE AND AGONISTIC CTL EPITOPES OF THE MUC1 TUMOR ANTIGEN
EP3412304A3 (en) 2013-10-23 2019-03-20 The United States of America, as represented by The Secretary, Department of Health and Human Services Hla-a24 agonist epitopes of muc1-c oncoprotein and compositions and methods of use
EP3331554B1 (en) 2015-08-03 2022-05-11 The U.S.A. as represented by the Secretary, Department of Health and Human Services Brachyury deletion mutants, non-yeast vectors encoding brachyury deletion mutants, and their use
AU2017355564B2 (en) 2016-11-07 2022-04-14 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Development of agonist epitopes of the human papillomavirus
WO2020102404A1 (en) 2018-11-14 2020-05-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Tp5, a peptide inhibitor of aberrant and hyperactive cdk5/p25 as treatment for cancer
EP4093432A1 (en) 2020-01-21 2022-11-30 The United States of America, as represented by the Secretary, Department of Health and Human Services Human immunogenic epitopes of hemo and hhla2 human endogenous retroviruses (hervs)
WO2021150713A2 (en) 2020-01-21 2021-07-29 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Human immunogenic epitopes of h, k, and e human endogenous retroviruses (hervs)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2009343C3 (de) * 1970-02-27 1980-10-23 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen Verwendung von Lysolecithinen als immunologische Adjuvantien
GB1502774A (en) * 1974-06-25 1978-03-01 Nat Res Dev Immunological preparations
US4196191A (en) * 1975-09-29 1980-04-01 Burroughs Wellcome Co. Biological preparations
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
GB2026340B (en) * 1978-07-03 1982-12-22 Ash P Stabilising microvesicles
US4199565A (en) * 1979-03-26 1980-04-22 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
HU184141B (en) * 1979-12-27 1984-07-30 Human Oltoanyagtermelo Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof
US4673574A (en) * 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4902506A (en) * 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates
US4761283A (en) * 1983-07-05 1988-08-02 The University Of Rochester Immunogenic conjugates
US4565696A (en) * 1983-08-03 1986-01-21 The Regents Of The University Of California Production of immunogens by antigen conjugation to liposomes
US4708933A (en) * 1984-06-12 1987-11-24 Leaf Huang Immunoliposome assay-methods and products
JPH0832637B2 (ja) * 1985-02-14 1996-03-29 アクゾ・エヌ・ヴエー 合成免疫原
US4797285A (en) * 1985-12-06 1989-01-10 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Lipsome/anthraquinone drug composition and method
US4882145A (en) * 1986-12-09 1989-11-21 Scripps Clinic And Research Foundation T cell epitopes of the hepatitis B virus nucleocapsid protein
EP0306912A3 (en) * 1987-09-08 1989-07-05 Albany Medical College Immunogenic composites capable of selectively inducing antibody production and pharmaceutical compositions employing the same.

Also Published As

Publication number Publication date
CN1059279A (zh) 1992-03-11
WO1992002243A1 (en) 1992-02-20
JPH06502630A (ja) 1994-03-24
PT98470A (pt) 1992-06-30
HK1008304A1 (en) 1999-05-07
FI107515B (fi) 2001-08-31
CN1032236C (zh) 1996-07-10
RU2107493C1 (ru) 1998-03-27
AU650299B2 (en) 1994-06-16
KR100213851B1 (ko) 1999-08-02
CA2088163C (en) 2003-06-17
DK0542923T3 (da) 1997-10-13
NO930202L (no) 1993-01-21
GR3025377T3 (en) 1998-02-27
NZ239072A (en) 1997-06-24
ZA915755B (en) 1993-02-24
NO311167B1 (no) 2001-10-22
EP0542923B1 (en) 1997-09-03
IL98935A (en) 1994-01-24
CA2088163A1 (en) 1992-01-28
FI930319A0 (fi) 1993-01-26
DE69127545D1 (de) 1997-10-09
US5464630A (en) 1995-11-07
EP0542923A4 (es) 1994-04-13
JP3518866B2 (ja) 2004-04-12
NO930202D0 (no) 1993-01-21
DE69127545T2 (de) 1998-01-08
IE912535A1 (en) 1992-01-29
EP0542923A1 (en) 1993-05-26
FI930319A (fi) 1993-01-26
IL98935A0 (en) 1992-07-15
ATE157537T1 (de) 1997-09-15
PT98470B (pt) 1998-02-27
AU8759791A (en) 1992-03-02

Similar Documents

Publication Publication Date Title
ES2106088T3 (es) Liposomas que proporcionan una ayuda timo-dependiente a antigenos de vacuna debiles.
EA199700272A1 (ru) Вакцины, содержащие сапонин и стерин
FI863730A (fi) Laekemedel innehaollande klorfluorkolvaete-aerosoldrivmedelkompositioner.
ES2115626T3 (es) Anticuerpo monoclonal humano especifico al antigeno de superficie de la membrana de las celulas cancerosas.
MY104946A (en) Antigen antibody conjugate.
RU93004915A (ru) Липосомы, осуществляющие тимус-зависимую помощь "слабым" антигенам, используемым для приготовления вакцины
FI962376A0 (fi) Siittiön zonaa sitovan proteiinin autoantigeenista epitooppia vastaavasiittiön antigeeni
ES2074062T3 (es) Inmunoensayo para antigenos hiv-1 que utilizan fragmentos de f(ab')2 como sonda.
ES2138102T3 (es) Procedimiento para la deteccion de antigeno urinario asociado a tumores.
FI924082A (fi) Idiotypvaccination mot b-cellymfoma
DK0474691T3 (da) Monoklonale antistoffer til induktion af tolerance
ATE2048T1 (de) Isolierung von hepatitis be-antigen.
KR890700683A (ko) 인체 면역 결핍 바이러스에 대한 항체 검색 방법
DE3850993D1 (de) Monoklonaler Antikörper spezifisch gegen humane Pankreas-Phospholipase-A2.
DE68917138T2 (de) Toleranzinduktion gegenüber einem fremdantigen.
FI923348A0 (fi) Laekemedel och foerfaranden foer kelandering av aids och aids-relaterade komplex (arc) med anvaendning av kolhydratantigener och antikroppar mot kolhydrater.
GR1000403B (el) Νεα ανοσοδιαγνωστικη μεθοδος
IT1230673B (it) Metodo per la immunolocalizzazione di antigeni con l'impiego di anticorpi diretti contro epitopi di natura non glucidica
IT1254147B (it) Metodo di rivelazione di marcatori tumorali.
BR7902674A (pt) Colhedeira de cafe com sistema de succao e vibracao atraves de grampos que abrem e fecham
BR1100952A (pt) Proteìna de fusão ctla4ig que se liga ao antìgeno b7
IT9043522A0 (it) Pendolo circolare accelerato dal galleggiante

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 542923

Country of ref document: ES